title: [Guidelines on prevention and treatment of vitamin D deficiency. Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)].
abstract: The Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS) has elaborated the following guidelines about the definition, prevention and treatment of inadequate vitamin D status. The highlights are presented here. Daily vitamin D allowance ranges from 1,500 IU (healthy adults) to 2,300 IU (elderly with low calcium intake). Since the average Italian diet includes around 300 IU/day, subjects with no effective sun exposure should be supplemented with 1,200-2,000 IU vitamin D per day. The serum 25-hydroxy-vitamin D [25(OH)D] levels represents the most accurate way to assess vitamin D repletion, even though there are still no standardized assay methods. Conditions of “deficiency” and “insufficiency” are defined by the following ranges of 25(OH)D levels: less than 20 ng/ml and 20-30 ng/ml, respectively. In Italy, approximately 50% of young healthy subjects have vitamin D insufficiency during the winter months. The prevalence of deficiency increases with ageing, affecting almost all elderly subjects not on vitamin D supplements. When a condition of deficiency has been identified, a cumulative dose of 300,000-1,000,000 IU, over 1-4 weeks is recommended. In subjects recently treated for deficiency-insufficiency, a maintenance dose of 800-2,000 IU/day (or weekly equivalent) is recommended. In patients on daily doses over 1,000 IU, 25(OH)D levels should be checked regularly (e.g. once every two years). The highest tolerated daily dose has been identified as 4,000 IU/day. Vitamin D supplementation should be carefully monitored in patients at higher risk of vitamin D intoxication (granulomatosis) or with primary hyperparathyroidism. In pregnant women, vitamin D supplements should be given as in non-pregnant women, but bolus administration (i.e.: single dose >25,000 IU) should be avoided.
authors.affiliation: Unità di Reumatologia, Dipartimento di Medicina, Università di Verona, Roma, Italia. Silvano.adami@univr.it
authors.forename: S
authors.initials: S
authors.lastname: Adami
authors.forename: E
authors.initials: E
authors.lastname: Romagnoli
authors.forename: V
authors.initials: V
authors.lastname: Carnevale
authors.forename: A
authors.initials: A
authors.lastname: Scillitani
authors.forename: A
authors.initials: A
authors.lastname: Giusti
authors.forename: M
authors.initials: M
authors.lastname: Rossini
authors.forename: D
authors.initials: D
authors.lastname: Gatti
authors.forename: R
authors.initials: R
authors.lastname: Nuti
authors.forename: S
authors.initials: S
authors.lastname: Minisola
mesh_terms: D000328:Adult; D000368:Aged; D002648:Child; D004032:Diet; D019587:Dietary Supplements; D005260:Female; D005598:Fractures, Spontaneous / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D020714:Maximum Tolerated Dose; D009751:Nutritional Requirements; D011247:Pregnancy; D015995:Prevalence; D012306:Risk; D013472:Sunlight; D014807:Vitamin D / Q000008:administration & dosage / Q000009:adverse effects / Q000502:physiology; D014808:Vitamin D Deficiency / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*
chemical_list: D014807:Vitamin D